(Q43944417)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215688%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

title

PEGylation enhancement of pH stability of uricase via inhibitive tetramer dissociation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215688%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215688%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Hong Tian

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215688%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Yuan Guo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215688%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Wenbing Yao

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215688%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

publication date

30 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215688%20AND%20SRC:MED&resulttype=core&format=json

Journal of Pharmacy and Pharmacology

19 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215688%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215688%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215688%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

53-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215688%20AND%20SRC:MED&resulttype=core&format=json

PEGylation, successful approach to drug delivery

19 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

Advances in PEGylation of important biotech molecules: delivery aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

PEGylation: an approach for drug delivery. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

Mechanism of poly(ethylene glycol) interaction with proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

Pharmacokinetic consequences of pegylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

Site-directed PEGylation as successful approach to improve the enzyme replacement in the case of prolidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

Increased activity and stability of poly(ethylene glycol)-modified trypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

Effect of PEG molecular weight and linking chemistry on the biological activity and thermal stability of PEGylated trypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

The case for uricase in gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

Urate oxidase (rasburicase) for treatment of severe tophaceous gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

Recombinant urate oxidase (rasburicase) for the prevention and treatment of tumor lysis syndrome in patients with hematologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

PEG-uricase in the management of treatment-resistant gout and hyperuricemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

High pressure macromolecular crystallography: the 140-MPa crystal structure at 2.3 A resolution of urate oxidase, a 135-kDa tetrameric assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

Cloning, sequence analysis, and expression in Escherichia coli of the gene encoding the Candida utilis urate oxidase (uricase).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

Oxygen Pressurized X-Ray Crystallography: Probing the Dioxygen Binding Site in Cofactorless Urate Oxidase and Implications for Its Catalytic Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

Improved performance of polyaniline-uricase biosensor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

Characterization, stabilization and activity of uricase loaded in lipid vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly(ethylene glycol) and poly(N-acryloylmorpholine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

X-ray scattering studies of Aspergillus flavus urate oxidase: towards a better understanding of PEG effects on the crystallization of large proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

Uricase and other novel agents for the management of patients with treatment-failure gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

Site-directed enzymatic PEGylation of the human granulocyte colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

Biochemical and biopharmaceutical properties of PEGylated uricase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01575.X

10.1111/J.2042-7158.2012.01575.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23215688%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference